Pasithea Therapeutics Corp. (KTTA) stock has reached a new 52-week low, trading at $1.32 USD, as investors navigate a tumultuous market environment. With a market capitalization of just $1.79 million ...
Pasithea Therapeutics Corp. (KTTA) stock has reached a new 52-week low, trading at $2.19, marking a 76% decline from its 52-week high of $9.25. This latest price point underscores a period of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback